Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

Last updated: April 23, 2025
Sponsor: Johns Hopkins Bloomberg School of Public Health
Overall Status: Active - Recruiting

Phase

N/A

Condition

Focal Segmental Glomerulosclerosis

Nephropathy

Kidney Failure

Treatment

N/A

Clinical Study ID

NCT00327860
DK66116
U01DK066143
U01DK066116
U01DK082194
U24DK066116
IRB10007880
U01DK066174
U24DK137522
IRB00011050
  • Ages 6-22
  • All Genders

Study Summary

The Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Heart, Lung and Blood Institute (NHLBI) funded a cooperative agreement including two Clinical Coordinating Centers (at Children's Hospital of Philadelphia and at Children's Mercy Hospital in Kansas City), a central biochemistry laboratory (at the University of Minnesota) and a Data Coordinating Center (at Johns Hopkins School of Public Health) to conduct a prospective epidemiological study of children with chronic kidney disease (CKD).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age between 1 and 16 years (before 17th birthday) for Cohorts 1 and 2; age between 6months and 16 years (before 17th birthday) for Cohort 3; age between 16 to 22 years (before 23rd birthday) for Cohort 4 and regularly seen by pediatric nephrologistprior to enrollment

  • Estimated (based on SCr) Schwartz GFR between 30 and 90 ml/min|1.73m2 for Cohort 1OR an estimated GFR between 45 and 90 ml/min|1.73m2 based on the updated Schwartzformula for Cohort 2; an estimated GFR ≤60 based on the CKiD Under 25 estimatingequation (U25eGFR) OR KRT experience (dialysis or transplant) for Cohort 4

  • Willingness and ability to provide informed consent and assent

  • For Cohort 3, children with non-glomerular diagnosis and duration of kidney diseaseless than 5 years will be enrolled.

Exclusion

Exclusion Criteria:

  • Solid organ (other than kidney), bone marrow or stem cell transplantation

  • Cancer diagnosis and receiving treatment or within 12 months post completion oftreatment

  • HIV diagnosis and receiving treatment or within 12 months post completion oftreatment

  • Current pregnancy or pregnancy within past twelve months

  • Inability to complete major data collection procedures

  • Not fluent in English or Spanish

  • Plans to move out of area of any participating CKiD site (families can betransferred to another CKiD site if the family moves)

  • Existing moderate to severe congenital structural heart disease

  • Genetic syndromes involving the central nervous system (e.g., Downs syndrome)

  • History of severe to profound intellectual disability (i.e., Intelligence Quotient (IQ)<40, significant impairment in adaptive function and/or inability toindependently execute self-care skills)

  • For cohort 3, children who are expected to receive renal replacement therapy within 6 months of date of enrollment will not be recruited

Study Design

Total Participants: 1300
Study Start date:
October 01, 2003
Estimated Completion Date:
July 31, 2028

Study Description

Since its inception in 2003, the scientific aims of CKiD have been to determine the risk factors for decline in kidney function and to define how progressive decline in kidney function impacts biomarkers of risk factors for cardiovascular disease; neurocognitive function and behavior; and growth failure and its associated morbidity.

The goals have been extended to understand the impact of childhood CKD on: the risk factors for decline in kidney function in childhood and young adulthood; the development of cardiovascular disease in adolescence and young adulthood; the trajectories of markers of metabolic bone disease and the relationship to cardiovascular endpoints; and the social function, neurocognitive function and emotional well-being of adolescents and young adults and the relationship to successful transfer to adult nephrology care.

Connect with a study center

  • Children's Mercy Kansas City

    Kansas City, Missouri 64108
    United States

    Active - Recruiting

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania 19146
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.